Skip to content
Buy This GLP
← Research
Evidence

How Long Before Pregnancy Should You Stop a GLP-1? What the Labels Say

The U.S. Wegovy label gives a two-month minimum before a planned pregnancy for weight or heart indications. Zepbound has no set interval.

Editorial profile: Neil SandersBuy This GLP Editorial Team3 min read
U.S. prescribing informationWegovy for weight or heart risk: at least 2 monthsZepbound: no set preconception interval on label

For weight management or cardiovascular risk reduction, the U.S. Wegovy label specifies at least two months before a planned pregnancy [1]. The U.S. Zepbound label gives no fixed interval before conception [2]. Bring the exact product and reason for taking it to a preconception visit.

What the U.S. labels say

For weight management or cardiovascular risk reduction, the Wegovy label also calls for stopping when pregnancy is recognized [1]. People taking Wegovy for MASH need a separate discussion about potential benefits and fetal risks. The label specifies the same two-month interval if potential risks outweigh benefits.

The Zepbound label addresses two decisions. Its warning about tirzepatide and birth control pills applies to preventing pregnancy. The label also calls for stopping Zepbound when pregnancy is recognized [2].

What pregnancy records can tell us

Our review of U.S. prescribing around pregnancy describes when prescriptions were recorded before and after delivery. Those records measure prescribing patterns. They cannot establish whether a medication is safe at a given point in pregnancy.

One health system matched 448 pregnancies with prior or early GLP-1 orders to 1,344 pregnancies without those orders [3]. The exposed group gained more weight during pregnancy, on average. The study design could not establish how much of the difference came from stopping the drug.

A multinational study included 938 infants with early GLP-1 prescription exposure among pregnancies in people with type 2 diabetes [4]. The adjusted risk ratio for major malformations versus insulin was 0.95 (95% CI 0.72 to 1.26). The estimate leaves uncertainty about risk. The study also grouped several GLP-1 drugs together.

What to bring to a preconception visit

Bring your medication name, the reason you use it, and the date of your last dose. Discuss a glucose management plan if you take the drug for diabetes. If pregnancy comes sooner than expected, contact the prescriber and obstetric team promptly about the specific drug and indication.

Frequently asked

What does the Wegovy label say about planning a pregnancy?
The U.S. label specifies at least two months before a planned pregnancy for weight management or cardiovascular risk reduction. For MASH, it specifies the interval if potential risks outweigh benefits.
What does the Zepbound label say about pregnancy?
The U.S. label calls for stopping when pregnancy is recognized. Discuss timing with the prescriber before trying to conceive.
What if you get pregnant while taking a GLP-1?
Contact your prescriber and obstetric team promptly. Share the exact drug and why you take it so the team can advise you.

Sources

  1. [1] Novo Nordisk (2026). WEGOVY (semaglutide) — prescribing information DailyMed, U.S. National Library of Medicine. Source
  2. [2] Eli Lilly and Company (2026). ZEPBOUND (tirzepatide) injection, for subcutaneous use — prescribing information DailyMed, U.S. National Library of Medicine. Source
  3. [3] Maya J, Pant D, Fu Y, James K, Batlle C, Hsu S, et al. (2025). Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation JAMA. PMID 41284263
  4. [4] Cesta CE, Rotem R, Bateman BT, Chodick G, Cohen JM, Furu K, et al. (2024). Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy JAMA Internal Medicine. PMID 38079178

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence